Aadi bioscience to report fourth quarter and full-year 2023 results and corporate update

Company to host conference call and webcast on march 13, 2024 los angeles , march 6, 2024 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mtor pathway alterations, today announced that it will host a conference call and live webcast on wednesday, march 13, 2024 at 8:30 am et (5:30 am pt) to report fourth quarter and full-year 2023 financial results and provide recent corporate updates. conference call information  participants may access a live webcast of the call on the "investors & news" page of the aadi bioscience website at  aadibio.com.
AADI Ratings Summary
AADI Quant Ranking